DE1617605C3 - Verfahren zum Herstellen eines Pertussis-Antigens - Google Patents

Verfahren zum Herstellen eines Pertussis-Antigens

Info

Publication number
DE1617605C3
DE1617605C3 DE19661617605 DE1617605A DE1617605C3 DE 1617605 C3 DE1617605 C3 DE 1617605C3 DE 19661617605 DE19661617605 DE 19661617605 DE 1617605 A DE1617605 A DE 1617605A DE 1617605 C3 DE1617605 C3 DE 1617605C3
Authority
DE
Germany
Prior art keywords
antigen
cell
pertussis
cells
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE19661617605
Other languages
German (de)
English (en)
Other versions
DE1617605B2 (de
DE1617605A1 (de
Inventor
Irving Willow Grove Pa. Millman (V.St.A.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE1617605A1 publication Critical patent/DE1617605A1/de
Publication of DE1617605B2 publication Critical patent/DE1617605B2/de
Application granted granted Critical
Publication of DE1617605C3 publication Critical patent/DE1617605C3/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE19661617605 1965-01-19 1966-01-18 Verfahren zum Herstellen eines Pertussis-Antigens Expired DE1617605C3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42669165A 1965-01-19 1965-01-19

Publications (3)

Publication Number Publication Date
DE1617605A1 DE1617605A1 (de) 1971-04-01
DE1617605B2 DE1617605B2 (de) 1974-01-31
DE1617605C3 true DE1617605C3 (de) 1974-08-29

Family

ID=23691819

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19661617605 Expired DE1617605C3 (de) 1965-01-19 1966-01-18 Verfahren zum Herstellen eines Pertussis-Antigens

Country Status (11)

Country Link
BE (1) BE675310A (enExample)
BR (1) BR6676474D0 (enExample)
DE (1) DE1617605C3 (enExample)
DK (1) DK115720B (enExample)
ES (1) ES322331A1 (enExample)
FR (2) FR1475742A (enExample)
GB (1) GB1119543A (enExample)
IL (1) IL24946A (enExample)
NL (1) NL6600703A (enExample)
NO (1) NO116869B (enExample)
SE (1) SE326797B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ188211A (en) * 1977-10-28 1984-09-28 American Cyanamid Co Isolation of polyribosyl ribitol phosphate(prp)from haemophilus influenzae type b;vaccine comprising prp and bordetellapertussis antigens
DE3043291A1 (de) * 1980-11-17 1982-07-01 Dso Pharmachim Vakzine gegen keuchhusten
US4474758A (en) * 1981-11-19 1984-10-02 American Cyanamid Company Haemophilus influenzae type b and pertussis outer membrane component combined vaccine
CN1265566A (zh) * 1997-06-04 2000-09-06 细胞改良有限公司 破碎生物材料的方法和装置

Also Published As

Publication number Publication date
BE675310A (enExample) 1966-07-19
ES322331A1 (es) 1966-11-16
NO116869B (enExample) 1969-06-02
GB1119543A (en) 1968-07-10
FR1475742A (fr) 1967-04-07
BR6676474D0 (pt) 1973-09-11
FR5550M (enExample) 1967-11-20
DE1617605B2 (de) 1974-01-31
DK115720B (da) 1969-11-03
SE326797B (enExample) 1970-08-03
IL24946A (en) 1969-05-28
NL6600703A (enExample) 1966-07-20
DE1617605A1 (de) 1971-04-01

Similar Documents

Publication Publication Date Title
DE69531782T2 (de) Heisswasser-Extrakt von Cordyceps sinensis
DE2735411A1 (de) Verfahren zur herstellung von acellulaeren vaccinen und nach diesem verfahren gewonnene vaccine
EP0222974B1 (de) Verfahren zur Herstellung eines Tollwutimpfstoffes und nach diesem Verfahren erhaltener Impfstoff
DE1492042A1 (de) Antigenherstellung
DE2457090C2 (de) Verfahren zur Herstellung von Impfstoffen sowie Antibronchialimpfstoff
DE1195905B (de) Verfahren zum Abtrennen der Zellwaende von Mycobacterium phlei
EP1124575A1 (de) Verfahren zur herstellung eines antiviralen mittels
DE1617605C3 (de) Verfahren zum Herstellen eines Pertussis-Antigens
DE2555169C2 (enExample)
DE2619715A1 (de) Tumor-antigen und verfahren zu dessen herstellung
CH659084A5 (de) Artifiziell erzeugter tollwutvirus-stamm und verfahren zu seiner gewinnung.
DE2352662A1 (de) Verfahren zur herstellung eines uebertragungsfaktors
DE2456636A1 (de) Influenza-vakzine und verfahren zu ihrer herstellung
DE1492042C (de) Verfahren zur Herstellung eines Pertussi-Antigens
DE2613943A1 (de) Verfahren zur herstellung von vaccinen auf ribonucleinsaeurebasis
DE1492243B2 (de) Injizierbare Impfstoffe
DE2134930A1 (de) Antigene Extrakte
DE397551C (de) Verfahren zur Gewinnung spezifischer Impfstoffe
DE2213709A1 (de) Verfahren zur Herstellung eines Interferonerzeugers
DE908909C (de) Verfahren zur Herstellung und Verarbeitung pathogener Viren und der sie begleitenden Stoffe
DE1966436C3 (de) Verwendung einer Antigen-Immunserum-Kombination als Impfstoff
DE3913438A1 (de) Verfahren zum herstellen einer immunitaetsgedaechtniszellsuspension
DE2016274A1 (enExample)
DD283330A5 (de) Zepareth-herstellungsverfahren aus selektierten zellinien begrenzter vermehrungspotenz (finit lines)
US4134885A (en) Anti-antihemocytic serum and a method for the preparation thereof

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)